According to the report, the size of the North America Dialysis Equipment Market is valued at USD 5.01 billion in 2021 and is predicted to reach USD 6.45 billion by 2026, growing at a CAGR of 5.2 % during the forecast period 2021 to 2026.
The factors driving the growth of the market are mainly attributed to the increase in the number of end-stage renal disease (ESRD) patients, the growing demand for peritoneal dialysis, the rise in popularity of cost-effective and accurate portable dialysis machines and advanced technologies for treatment of ESRD.
Expected growing geriatric population increase the number of old age people with chronic diseases suffering from complication that may include renal disorders. Owing to more patients, The Government have increased the number of dialysis centers facilitated by public or private funds
Rising awareness of renal disorders and types of treatments available along with its complications drives the dialysis equipment market growth in North American region.
R&D spending on new dialysis products such as home dialysis machines to help reduce the number of hospital visits contributes towards market growth.
However, factors such as complications and risks associated with dialysis and reimbursement issues may hamper the growth of the market during the forecast period. High cost for the treatment, implementation of stringent regulations and lack of skilled workforce such as nephrologists in the emerging markets will restraint the North America renal dialysis equipment market growth in the forecast period of 2021 - 2026.
Technological advances in the health field are leading to the development of hemodialysis devices with improved ergonomics. US FDA approval for the clinical trial of the on-demand peritoneal dialysis solution generation systems will give better opportunities for dialysis treatment. The new system provides a good platform for patients to perform dialysis at home. The growing rate of renal diseases among North American population across the regions is escalating the growth of the renal dialysis equipment market.
Lack of awareness of kidney disease hinders market growth rate along with extremely competitive market for small and medium-sized businesses challenges the market growth in the regions.
This research report on the North America Dialysis Equipment Market has been segmented and sub-segmented into the following categories
By End User:
North America region will hold over 26% revenue share of the global renal dialysis equipment market by the end of 2019, but the market will lose its luster by the end of 2025 due to the emerging competition in other parts of the world. The large number of dialysis patients and the adoption of advanced technologies in the field of dialysis equipment are factors that are expected to help the North American regional market.
In the North America region, the United States and Canada are expected to dominate with their outstanding performance during the forecast period. The US kidney dialysis equipment market is expected to experience steady growth due to the massive adoption of new technologies in the kidney dialysis division. Manufacturers are also lining up for specialized hemodialysis, as well as peritoneal dialysis machines with different procedures, which will also affect the end-user experience. The boom in public health spending in Canada should open a new development path for the Canadian renal dialysis equipment market. Both the U.S and Canada are expected to have healthy steady growth rate in the forecasted period.
Promising Companies leading the North America Dialysis Equipment Market Profiled in the Report are Fresenius Medical Care AG & Co., Gambro AB, Baxter International Inc., Nipro Inc., ALL-MED Medical GmbH, Asahi Kasei Corporation, and others.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.2 Hemodialysis Equipment
18.104.22.168 Hemodialysis Machines
22.214.171.124 Blood Access Device Dialysate
5.1.3 Peritoneal Dialysis Equipment
126.96.36.199 Continuous Cycling Peritoneal Dialysis
188.8.131.52 Continuous Ambulatory Peritoneal Dialysis
184.108.40.206 Intermittent Peritoneal Dialysis
5.1.4 Continuous Renal Replacement Therapy Systems
5.1.5 Dialysis Accessories
5.1.6 Y-o-Y Growth Analysis, By Type
5.1.7 Market Attractiveness Analysis, By Type
5.1.8 Market Share Analysis, By Type
5.3.2 In-Center Dialysis
5.3.3 Homecare Dialysis
5.3.4 Y-o-Y Growth Analysis, By End User
5.3.5 Market Attractiveness Analysis, By End User
5.3.6 Market Share Analysis, By End User
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
220.127.116.11 By Geographical Area
18.104.22.168 By Type
22.214.171.124 By End User
6.1.4 Market Attractiveness Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By Type
184.108.40.206 By End User
6.1.5 Market Share Analysis
220.127.116.11 By Geographical Area
18.104.22.168 By Type
22.214.171.124 By End User
6.2 United States
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Fresenius Medical Care AG & Co.
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Gambro AB
8.3 Baxter International Inc.
8.4 Nipro Inc.
8.5 ALLMED Medical GmbH
8.6 Asahi Kasei Corporation
8.7 Celgene Corporation
8.9 Cytori Therapeutics
8.10 Retractable Technologies
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures